Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis

被引:16
作者
Ichimura-Shimizu, Mayuko [1 ]
Omagari, Katsuhisa [2 ]
Yamashita, Michiko [3 ]
Tsuneyama, Koichi [1 ]
机构
[1] Tokushima Univ, Dept Pathol & Lab Med, Grad Sch, Tokushima, Japan
[2] Univ Nagasaki, Grad Sch Human Hlth Sci, Div Nutr Sci, Nagasaki, Japan
[3] Tokushima Univ, Dept Analyt Pathol, Grad Sch, Tokushima, Japan
基金
日本学术振兴会;
关键词
nonalcoholic steatohepatitis; fibrosis; diet; Tsumura-Suzuki non obese mice; mouse model; ANIMAL-MODELS; OBETICHOLIC ACID; HIGH-FAT;
D O I
10.1093/bbb/zbaa107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonalcoholic steatohepatitis (NASH) progresses to liver fibrosis and cirrhosis. Existing mouse models of NASH rarely develop diet-induced severe fibrosis. We aimed to establish a dietary model of NASH with rapid progression to fibrosis. Six-week-old male Tsumura-Suzuki obese diabetes (TSOD) mice (a model of spontaneous metabolic syndrome) and corresponding control Tsumura-Suzuki nonobese (TSNO) mice were fed a novel diet high in fat, cholesterol, and cholate (iHFC). Histologic steatohepatitis, including steatosis, inflammation, and fibrosis, were observed in both TSNO and TSOD iHFC diet-fed mice at 20 weeks of age. As compared with TSOD mice, TSNO mice developed much more severe fibrosis and reached stage 3 of bridging fibrosis within 14 weeks under the iHFC diet feeding. Perivenular/perisinusoidal pattern of fibrosis in TSNO mice resembled human NASH. Our model of NASH with advanced fibrosis by simple diet offers many advantages useful in studying the mechanism of liver fibrosis and preclinical drug testing.
引用
收藏
页码:941 / 947
页数:7
相关论文
共 26 条
[21]   Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse) [J].
Takahashi, Tetsuyuki ;
Nishida, Takeshi ;
Baba, Hayato ;
Hatta, Hideki ;
Imura, Johji ;
Sutoh, Mitsuko ;
Toyohara, Syunji ;
Hokao, Ryoji ;
Watanabe, Syunsuke ;
Ogawa, Hirohisa ;
Uehara, Hisanori ;
Tsuneyama, Koichi .
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (02) :267-270
[22]   Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis [J].
Takahashi, Yoshihisa ;
Fukusato, Toshio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) :15539-15548
[23]   A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer [J].
Tsuchida, Takuma ;
Lee, Youngmin A. ;
Fujiwara, Naoto ;
Ybanez, Maria ;
Allen, Brittany ;
Martins, Sebastiao ;
Fiel, M. Isabel ;
Goossens, Nicolas ;
Chou, Hsin-I. ;
Hoshida, Yujin ;
Friedman, Scott L. .
JOURNAL OF HEPATOLOGY, 2018, 69 (02) :385-395
[24]   Animal models for analyzing metabolic syndrome-associated liver diseases [J].
Tsuneyama, Koichi ;
Nishitsuji, Kazuchika ;
Matsumoto, Minoru ;
Kobayashi, Tomoko ;
Morimoto, Yuki ;
Tsunematsu, Takaaki ;
Ogawa, Hirohisa .
PATHOLOGY INTERNATIONAL, 2017, 67 (11) :539-546
[25]   Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis [J].
Wang, Qianyi ;
You, Hong ;
Ou, Xiaojuan ;
Zhao, Xinyan ;
Sun, Yameng ;
Wang, Min ;
Wang, Ping ;
Wang, Yu ;
Duan, Weijia ;
Wang, Xiaoming ;
Wu, Shanshan ;
Kong, Yuanyuan ;
Saxena, Romil ;
Gouw, Annette S. H. ;
Jia, Jidong .
HEPATOLOGY INTERNATIONAL, 2019, 13 (06) :766-776
[26]   Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c [J].
Watanabe, M ;
Houten, SM ;
Wang, L ;
Moschetta, A ;
Mangelsdorf, DJ ;
Heyman, RA ;
Moore, DD ;
Auwerx, J .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (10) :1408-1418